J
Jeffrey R. Strawn
Researcher at University of Cincinnati
Publications - 246
Citations - 5593
Jeffrey R. Strawn is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Anxiety & Medicine. The author has an hindex of 34, co-authored 195 publications receiving 4347 citations. Previous affiliations of Jeffrey R. Strawn include Cincinnati Children's Hospital Medical Center & University of Cincinnati Academic Health Center.
Papers
More filters
Journal ArticleDOI
Neuroleptic Malignant Syndrome
TL;DR: Demographic and clinical features, diagnosis, treatment, outcome, and pathophysiology are critically reviewed, and a new set of diagnostic criteria, incorporating physical signs and routine laboratory tests, is proposed.
Journal ArticleDOI
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
TL;DR: Studies of central noreadrenergic hyperactivity under both basal and challenge conditions are reviewed and the evidence for these derangements as potential psychopharmacologic targets in patients with PTSD is explored.
Journal Article
The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation.
Sarah A. Mossman,Marissa J. Luft,Heidi K. Schroeder,Sara T. Varney,David E. Fleck,Drew H. Barzman,Richard Gilman,Melissa P. DelBello,Jeffrey R. Strawn +8 more
TL;DR: The GAD-7 is associated with acceptable specificity and sensitivity for detecting clinically significant anxiety symptoms and may be more efficient than the PARS.
Journal ArticleDOI
Assessment and Treatment of Anxiety Disorders in Children and Adolescents
Anna M. Wehry,Katja Beesdo-Baum,Meghann M. Hennelly,Sucheta Connolly,Jeffrey R. Strawn,Jeffrey R. Strawn +5 more
TL;DR: Current data support cognitive behavioral therapy (CBT) for the treatment of fear-based anxiety disorders in youth and suggest that the combination of psychotherapy+ an SSRI may be associated with greater improvement than would be expected with either treatment as monotherapy.
Journal ArticleDOI
Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression
Thomas D. Geracioti,Linda L. Carpenter,Michael J. Owens,Dewleen G. Baker,Nosakhare N. Ekhator,Paul S. Horn,Jeffrey R. Strawn,Gerard Sanacora,Becky Kinkead,Lawrence H. Price,Charles B. Nemeroff +10 more
TL;DR: In this article, the authors tested the hypothesis that concentrations of the pain-transmitting neuropeptide substance P are elevated in the CSF of patients with major depression or posttraumatic stress disorder (PTSD), which have overlapping symptoms.